The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda

AIDS Research and Therapy

Volumn 6, Issue , 2009, Pages

  Kigozi, Brian K ^a   Sumba, Samwel ^a   Mudyope, Peter ^a   Namuddu, Betty ^a   Kalyango, Joan ^a   Karamagi, Charles ^a   Odere, Mathew ^b   Katabira, Elly ^a   Mugyenyi, Peter ^b   Ssali, Francis ^b  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^b JOINT CLINICAL RESEARCH CENTRE   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ADULT; AIDS RELATED COMPLEX; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCAL MENINGITIS; ESOPHAGUS CANDIDIASIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SURVIVAL; TOXOPLASMOSIS; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS LOAD; WASTING SYNDROME;

EID: 69349095853     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-6-17     Document Type: Article

References (32)

1. WHO Antiretroviral therapy for HIV infection in adults and adolescents. recomendations for a public health approach 2006 http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf
2. Amolo-Okero F Aceng E Madraa E Namagala E Serutoke J Scaling up antiretroviral Therapy: Experience in Uganda WHO 2003 http://www.emro.who.int/aiecf/web46.pdf
3. Uganda National Antiretroviral Treatment Guidelines for Adults, Adolescents and Children Ministry of Health 2008.
4. Lawn S Wood R How can earlier entry of patients into antiretroviral programs in low-income countries be promoted? Clin Infect Dis 2006, 42:431-432. http://www.journals.uchicago.edu/doi/abs/10.1086/ 499527?url_ver=Z39.88-2003&rfr_id= ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov
5. Lederman HM Williams PL Wu JW Evans TG Cohn SG McCutchan JA Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion J Infect Dis 2003, 188:1794-1803. 10.1086/379900 14673757
6. Lawn S Bekker L Robin R How effectively does HAART restore immune responses to Mycobacterium tuberculosis? AIDS 2005, 19:1113-1124. 15990564
7. Weidle PJ Malamba S Mwebaze R Sozi C Rukundo G Downing R Hanson D Ochola D Mugyenyi P Mermin J Samb B Lackritz E Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance Lancet 2006, 360(9326):34-40. 10.1016/ S0140-6736(02)09330-3
8. WHO World Health Organization Clinical Staging System 1993.
9. Moreno S Hernández B Dronda F Antiretroviral therapy in AIDS patients with tuberculosis AIDS Rev 2006, 8(3):115-124. 17078482
10. Ungsedhapand C Srasuebkul P Cardiello P Ruxrungtham K Ratanasuwan W Kroon ED Tongtalung M Juengprasert N Ubolyam S Siangphoe U Emery S Lange JM Cooper DA Phanuphak P HIV-NAT 002 and HIV-NAT 003 Study Team Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection J Acquir Immune Defic Syndr 2004. 36(2):693-701. 10.1097/00126334-200406010-00006 15167288
11. Yamashita TE Phair JP Muñoz A Margolick JB Detels R O'Brien SJ Mellors JW Wolinsky SM Jacobson LP Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study AIDS 2001, 156(6):735-746. 10.1097/00002030-200104130-00009 11371688
12. Le Moing V Thiébaut R Chêne G Sobel A Massip P Collin F Meyohas M Al Kaïed F Leport C F R Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs HIV Med 2007, 8(3):156-163. 10.1111/ j.1468-1293.2007.00446.x 17461859
13. Lima VD Harrigan R Murray M Moore DM Wood E Hogg RS Montaner JS Differential impact of adherence on long-term treatment response among naive HIV-infected individuals AIDS 2008, 22(17):2371-2380. 10.1097/ QAD.0b013e328315cdd3 18981777
14. Mahesh KP Machin D Survival analysis. A practical approach John Wiley & Sons 1996.
15. Giordano TP Wright JA Hasan MQ White AC Jr Graviss EA Visnegarwala F Do Sex and Race/Ethnicity Influence CD4 Cell Response in Patients Who Achieve Virologic Suppression during Antiretroviral Therapy? Clin Infect Dis 2003, 37(3):433-437. 10.1086/376638 12884169
16. Lawn SD Myer L Bakker LG Wood R CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa BMC Infect Dis 2006, 6:59. 1435908 16551345 10.1186/1471-2334-6-59
17. Barlett JG Gallant J Medical management of HIV infection John Hopkins Medicine Health Publishing Group 2007.
18. Lawn SD Butera ST Folks TM Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection Clin Microbiol Reviews 2001, 14(4):753-777. 10.1128/ CMR.14.4.753-777.2001
19. Battegay M Nuesch R Hirschel B Kauffman R Immunological recovery and antiretroviral therapy in HIV infection Lancet Infect Dis 2006, 6(5):280-287. 10.1016/S1473-3099(06)70463-7 16631548
20. Anastos K Kalish LA Hessol N Weiser B Melnick S Burns D Delapenha R DeHovitz J Cohen M Meyer W Bremer J Kovacs A The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study AIDS 2000, 13(13):1717-1726. 10.1097/00002030-199909100-00016
21. Coakley EP Samore MH Gillis JM Hughes MD Hammer SM The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 × 10(6) cells/l AIDS 2000, 14(9):1147-1153. 10.1097/ 00002030-200006160-00011 10894278
22. Holmes CB Losina E Walensky RP Yazdanpanah Y Freedberg KA Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa Clin Infect Dis 2003, 36(5):652-662. 10.1086/367655 12594648
23. Muyingo SK Walker AS Reid A Munderi P Gibb DM Ssali F Levin J Katabira E Gilks C Todd J Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe J Acquir Immune Defic Syndr 2008, 48(4):468-475. 10.1097/QAI.0b013e31817dc3fd 18614918
24. Paterson DL Swindells S Mohr J Brester M Vergis EN Squier C Wagener MM Singh N Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 2000, 133(1):21-30. 10877736
25. Lau B Gange SJ Phair JP Riddler SA Detels R Margolick JB Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection Jaids-Journal of Acquired Immune Deficiency Syndromes 2005, 39(5):620-625. http://journals.lww.com/jaids/Fulltext/2005/08150/ Use_of_Total_Lymphocyte_Count_and_Hemoglobin.18.aspx
26. Gange SJ Lau B Phair J Riddler SA Detels R Margolick JB Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy AIDS 2003, 17(1):119-121. 10.1097/00002030-200301030-00016 12478077
27. Hynes B Markert M Sempowski GD Patel DD Hale LP The role of thymus in immune reconstitution in aging, Bone marrow transplantation, and HIV-1 infection Annul Rev Immunol 2000, 18:529-560. 10.1146/ annurev.immunol.18.1.529
28. Patterson K Napravnik S Eron J Keruly J Moore R Effects of Age and Sex on Immunological and Virological Responses to Initial Highly Active Antiretroviral Therapy HIV Med 2007, 8(6):406-410. 10.1111/ j.1468-1293.2007.00485.x 17661850
29. Castetbon K Anglaret XTS Chene G Ouassa T Attia A N'Dri-Yoman T Malvy D Salamon R Dabis F Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adultsin Abidjan, Cote d'Ivoire American Journal of Epidemiology 2001, 154(1):75-84. 10.1093/aje/154.1.75 11427407
30. Thiébaut R Malvy D Marimoutou C Davis F Anthropometric indices as predictors of survival in AIDS adults. Aquitane cohort, France, 1985-1997 Eur Journ of Epidemiol 2000, 16(7):633-639. 10.1023/ A:1007696530440
31. Ssali FN Kamya MR Wabwire-Mangen F Kasasa S Joloba M Williams D Mugerwa RD Ellner JJ Johnson JL A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda J Acquir Immune Defic Syndr Hum Retrovirol 1998, 19(5):484-489. 9859962
32. Kumarasamy N Chaguturu S Mayer KH Solomon S Yepthomi HT Balakrishnan P Flanigan TP Incidence of immune reconstitution syndrome in HIV/ tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India J Acquir Immune Defic Syndr 2004, 37(5):1574-1576. 10.1097/00126334-200412150-00007 15577411